Dier Mardi Insider Trading Activity

Average Profitability
34.76%
Insider Buys Quantity
1
Insider Buys Sum
$380,000.00
Insider Sells Quantity
7
Insider Sells Sum
$1.5M

Insider Activity of Dier Mardi

According to the SEC Form 4 filings, Dier Mardi, being in a position of

  1. EVP and CFO at Madrigal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7338 shares for $3.77M,
    over all time since 2025-03-03, has bought 0 shares, and sold 9557 shares for $4.49M.

Biography of Dier Mardi

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,772,7983100

Comparison of Insiders on Amount of Buys and Sells

2026-03-06SaleMadrigal Pharmaceuticals, Inc.
MDGL
EVP and CFO
1,982
0.0087%
$430.87$853,993+18.78%
2026-03-02SaleMadrigal Pharmaceuticals, Inc.
MDGL
EVP and CFO
1,183
0.0052%
$427.21$505,389+17.93%
2025-12-02SaleMadrigal Pharmaceuticals, Inc.
MDGL
EVP and CFO
4,173
0.019%
$578.34$2.41M-10.46%
2025-03-10SaleMadrigal Pharmaceuticals, Inc.
MDGL
SVP and CFO
258
0.0011%
$323.04$83,344+29.07%
2025-03-03SaleMadrigal Pharmaceuticals, Inc.
MDGL
SVP and CFO
1,961
0.0092%
$324.96$637,248+34.46%
2022-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
1,629
0.0025%
$40.16$65,421+13.09%
2022-10-12SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
3,484
0.0049%
$38.22$133,158+8.89%
2022-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
420
0.0006%
$64.55$27,111-29.29%
2021-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
3,261
0.0048%
$81.16$264,663-17.23%
2021-10-12SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
3,477
0.0051%
$82.79$287,861-18.74%
2020-09-29PurchasePrelude Therapeutics Incorporated
PRLD
director
20,000
0.4125%
$19.00$380,000+34.76%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.